Community Corner
Clinical Trial Recruiting for Parkinson's Disease Patients
At the University of California, Neal Harmanowicz, M.D., is seeking volunteers in the Irvine, CA area to participate in a Parkinson's disease (PD) clinical research study evaluating the effects of the investigational use of AZILECT® (rasagiline
tablets) on mild cognitive impairment (PD-MCI). Currently, there are no treatments available indicated for PD-MCI, so any therapy demonstrating a benefit would be a welcomed step toward meeting a significant unmet need in the community.
The trials are targeted to women and men from age 45 to 80 years old with Parkinson’s disease, meeting specified criteria which can be found here. The recruitment period will continue through March 2014 and your community is one of 44 sites that will participate around the country.
- This clinical trial, sponsored by Teva Pharmaceuticals, will not only further the understanding of Parkinson’s disease and a potential treatment but will also provide participants with:Clinical trial participation at no cost;Study related care at a healthcare facility; and Study related health care monitoring.